Dr. Jennifer L. Taylor-Cousar, MD

Dr. Taylor-Cousar practices at National Jewish Health in Denver, Colorado, part of National Jewish Health.

Dr. Taylor-Cousar's NPI, 1104912575, was assigned on October 5, 2006. Dr. Taylor-Cousar graduated from Duke University School of Medicine in 1998. Dr. Taylor-Cousar holds Colorado license 48114.

Dr. Taylor-Cousar's primary practice is National Jewish Health, at 1400 Jackson St, Denver, CO 80206 in Denver County. The practice phone is (303) 388-4461.

Dr. Taylor-Cousar's primary practice is National Jewish Health in Denver, Colorado, part of National Jewish Health. The medical group on file is National Jewish Health. Dr. Taylor-Cousar's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Taylor-Cousar practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Taylor-Cousar's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Taylor-Cousar is licensed in Colorado.

CMS data shows 35 Medicare services from Dr. Taylor-Cousar across 1 procedure code in 2024, all of them office visits, for 17 Medicare patients. Medicare paid $3,748 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 17 Medicare patients who saw Dr. Taylor-Cousar in 2024. The largest group is 85 and over, with 0 patients. 65% of them have copd. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Taylor-Cousar's median patient age at 46, with 70% women.

In 2024, Dr. Taylor-Cousar wrote 631 Medicare Part D claims for 17 patients. 51% of them were for generic drugs. CMS names the drug for 433 of them, across 18 drugs with 11 or more claims each, at $4,480,096 in total drug cost. In 2023, CMS named 403 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Taylor-Cousar for performance year 2024, reported as part of a group. Dr. Taylor-Cousar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Taylor-Cousar as offering telehealth.

Dmand AI links 98 papers to Dr. Taylor-Cousar, published from 2011 to 2025. 2023 was the busiest year, with 16. The most frequent topics are Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator and Aminophenols. Dr. Taylor-Cousar has published most often in J Cyst Fibros. Dr. Taylor-Cousar's most frequent co-authors are Raksha Jain, MD, Traci Kazmerski and Milene Saavedra, MD.

Dmand AI links Dr. Taylor-Cousar to 6 clinical trials, 3 of them phase 2 studies. Conditions studied include Cystic Fibrosis and Infant, Newborn, Diseases. National Jewish Health sponsors the most, 3. Open Payments lists research payments to Dr. Taylor-Cousar that name 1 trial.

CMS Open Payments shows 347 general payments to Dr. Taylor-Cousar from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. Vertex Pharmaceuticals Incorporated paid the most, $244,742. It also lists 4 research payments totaling $6,700 from 2020 to 2022, naming 1 clinical trial.

Dr. Taylor-Cousar graduated from Duke University School of Medicine in 1998.